• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » ACC 2012: Bypass surgery beats PCI at 4 years | MassDevice.com On Call

ACC 2012: Bypass surgery beats PCI at 4 years | MassDevice.com On Call

March 27, 2012 By MassDevice staff

MassDevice On Call

MASSDEVICE ON CALL — Coronary artery bypass surgery beat out percutaneous stenting for mortality rates after 4 years in a large observational study of nearly 200,000 patients aged 65 and older, according to a new study unveiled at this week’s American College of Cardiology conference in Chicago.

The analysis was adjusted to control for factors such as age, sex, diabetes, renal function and lung disease, and researchers concluded that CABG patients lived longer, "even among patients whose propensity scores were most consistent with selection for PCI."

Adjusted 4-year all-cause mortality was 20% lower among CABG patients than for those who underwent PCI for coronary disease in 2 or 3 vessels, TheHeart.org reported.

Among the PCI group, more than ¾ received drug-eluting stents, about 16% received bare-metal stents and 6% had PCI without stenting.

Docs laud Obamacare at 2 years

The American College of Physicians called President Barack Obama’s signature health care reform a measure that "has resulted in major improvements in access and coverage for tens of millions of Americans seen by internal medicine physicians," calling the mandate for individual carriage of insurance "necessary to help protect and ensure the health of the American people," according to a press release.

Docs use electric pulse therapy on inoperable pancreatic cancer

A small study of patients with inoperable pancreatic cancer found promise in using electrical pulse therapy to target inoperable pancreatic tumors, according to a press release.

Stenting OK for the elderly, docs say

Researchers at Thomas Jefferson University deemed carotid artery stenting safe and effective in patients over the age of 70, according to a press release.

TAVI beats open-heart surgery among heart patients

Patients diagnosed with aortic stenosis who were too sick for major surgery fared better when treated with catheter-based heart valve replacement than with standard open-heart surgery, according to a press release.

Filed Under: Healthcare Reform, News Well, Oncology, Replacement Heart Valves, Stents Tagged With: American College of Cardiology, On Call

More recent news

  • Medtronic Diabetes names CFO with consumer experience ahead of separation
  • Preceptis Medical has a new CEO as it advances ear tube tech
  • FDA clears first over-the-counter cuffless blood pressure monitor
  • Mendaera wins FDA clearance for robotic needle placement
  • Johnson & Johnson seeks to have $442 million antitrust verdict tossed out

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy